Conformationnally restricted naphthalene derivatives type isocombretastatin A-4 and isoerianin analogues: Synthesis, cytotoxicity and antitubulin activity
摘要:
A novel series of dihydronaphtalene, tetrahydronaphtalene and naphtalene derivatives as restricted analogues of isoCA-4 were designed, synthesized and evaluated for their anticancer properties. High cell growth inhibition against four tumour cell lines was observed at a nanomolar level with dihydronaphtalenes 1d, e and 1h, tetrahydronaphtalene 2c and naphtalene 3c. Structure activity relationships are also considered. These compounds exhibited a significant inhibitory activity toward tubulin polymerization (IC50 = 2-3 mu M), comparable to that of isoCA-4. The effect of the lead compounds le and 2c on the cancer cells tested was associated with cell cycle arrest in the G(2)/M phase. Docking studies reveal that these compounds showed a binding mode similar to those observed with their non-constraint isoCA-4 and isoerianin congeners. (C) 2012 Elsevier Masson SAS. All rights reserved.
Conformationnally restricted naphthalene derivatives type isocombretastatin A-4 and isoerianin analogues: Synthesis, cytotoxicity and antitubulin activity
摘要:
A novel series of dihydronaphtalene, tetrahydronaphtalene and naphtalene derivatives as restricted analogues of isoCA-4 were designed, synthesized and evaluated for their anticancer properties. High cell growth inhibition against four tumour cell lines was observed at a nanomolar level with dihydronaphtalenes 1d, e and 1h, tetrahydronaphtalene 2c and naphtalene 3c. Structure activity relationships are also considered. These compounds exhibited a significant inhibitory activity toward tubulin polymerization (IC50 = 2-3 mu M), comparable to that of isoCA-4. The effect of the lead compounds le and 2c on the cancer cells tested was associated with cell cycle arrest in the G(2)/M phase. Docking studies reveal that these compounds showed a binding mode similar to those observed with their non-constraint isoCA-4 and isoerianin congeners. (C) 2012 Elsevier Masson SAS. All rights reserved.
TUBULIN BINDING LIGANDS AND CORRESPONDING PRODRUG CONSTRUCTS
申请人:BAYLOR UNIVERSITY
公开号:EP1263763A2
公开(公告)日:2002-12-11
TUBULIN BINDING LIGANDS
申请人:BAYLOR UNIVERSITY
公开号:EP1263763B1
公开(公告)日:2007-07-25
BENZOSUBERENE ANALOGUES AND RELATED COMPOUNDS WITH ACTIVITY AS ANTICANCER AGENTS
申请人:Baylor University
公开号:EP3836910A1
公开(公告)日:2021-06-23
[EN] TUBULIN BINDING LIGANDS AND CORRESPONDING PRODRUG CONSTRUCTS<br/>[FR] LIGANDS DE LIAISON DE TUBULINE ET CONSTRUCTIONS CORRESPONDANTES DE PROMEDICAMENTS
申请人:UNIV BAYLOR
公开号:WO2001068654A2
公开(公告)日:2001-09-20
A diverse set of tubulin binding ligands have been discovered which are structural by characterized, in a general sense, by a semi-rigid molecular framework capable of maintaining aryl-aryl, pseudo pi stacking distances appropriate for molecular recognition of tubulin. In phenolic or amino form, these ligands may be further functionalized to prepare phosphate esters, phosphate salts, and phosphoramides capable of demonstrating selective targeting and destruction of tumor cell vasculature.
[EN] BENZOSUBERENE ANALOGUES AND RELATED COMPOUNDS WITH ACTIVITY AS ANTICANCER AGENTS<br/>[FR] ANALOGUES DE BENZOSUBERÈNE ET COMPOSÉS APPARENTÉS AYANT UNE ACTIVITÉ EN TANT QU'AGENTS ANTICANCÉREUX
申请人:UNIV BAYLOR
公开号:WO2020037209A1
公开(公告)日:2020-02-20
A series of benzosuberene analogues demonstrate effective inhibition of tubulin polymerization, cytotoxicity against human cancer cell lines, and vascular dismption in tumors.